| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratory of Molecular Neuro-Oncology, Department of Neurosurgery, Emory University, Atlanta, Georgia 30322
In this study the expression of p16INK4, retinoblastoma protein (pRb), and cdk4 proteins have been examined in 18 malignant glioma cell lines and in 45 malignant glial tumors. Loss of p16INK4 expression associated with p16INK4 gene homozygous deletion was evident in 12 cell lines and in 10 primary tumors. Lack of p16INK4 expression was also evident in five tumors for which there was no evidence of p16INK4 gene homozygous deletion. Two of the cell lines and six of the primary tumors in which p16INK4 was present were determined to overexpress cdk4 in association with CDK4 gene amplification. Absence of pRb was determined in two of the cell lines and in ten of the tumors. In total, 16 of 18 cell lines and 25 of 45 tumors showed either a lack of p16INK4 or pRb or amplification-associated overexpression of cdk4. Two additional tumors showed an absence of pRb and p16INK4, and one tumor showed a lack of pRb combined with amplification-associated overexpression of cdk4. These results suggest a common growth-regulatory mechanism that is disrupted in gliomas by either suppressing the expression of p16INK4 or pRb or by increasing the expression of cdk4.
1 Supported by National Cancer Institute Grant CA-55728, as well as by generous gifts from MBNA and the Brain Tumor Foundation for Children, Atlanta, GA.
2 To whom requests for reprints should be addressed, at Department of Neurosurgery, Emory University, 1639 Pierce Drive, WMRB Room 6316, Atlanta, GA 30322. Phone: (404) 727-1450; Fax: (404) 727-4614.
Received 8/ 8/95. Accepted 9/ 1/95.
This article has been cited by other articles:
|
|
 |
|
  I. F. Pollack, R. L. Hamilton, R. W. Sobol, J. Burnham, A. J. Yates, E. J. Holmes, T. Zhou, and J. L. Finlay O6-Methylguanine-DNA Methyltransferase Expression Strongly Correlates With Outcome in Childhood Malignant Gliomas: Results From the CCG-945 Cohort J. Clin. Oncol., July 20, 2006; 24(21): 3431 - 3437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Reardon, J. N. Rich, H. S. Friedman, and D. D. Bigner Recent Advances in the Treatment of Malignant Astrocytoma J. Clin. Oncol., March 10, 2006; 24(8): 1253 - 1265. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Kim, H.-H. L. Hong, Y. Lachat, N. P. Clayton, T. R. Devereux, R. L. Melnick, M. E. Hegi, and R. C. Sills Genetic Alterations in Brain Tumors Following 1,3-Butadiene Exposure in B6C3F1 Mice Toxicol Pathol, April 1, 2005; 33(3): 307 - 312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-S. Chim, T.-K. Fung, W.-C. Cheung, R. Liang, and Y.-L. Kwong SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway Blood, June 15, 2004; 103(12): 4630 - 4635. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Backlund, B. R. Nilsson, H. M. Goike, E. E. Schmidt, L. Liu, K. Ichimura, and V. P. Collins Short Postoperative Survival for Glioblastoma Patients with a Dysfunctional Rb1 Pathway in Combination with No Wild-type PTEN Clin. Cancer Res., September 15, 2003; 9(11): 4151 - 4158. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Uhrbom, C. Dai, J. C. Celestino, M. K. Rosenblum, G. N. Fuller, and E. C. Holland Ink4a-Arf Loss Cooperates with KRas Activation in Astrocytes and Neural Progenitors to Generate Glioblastomas of Various Morphologies Depending on Activated Akt Cancer Res., October 1, 2002; 62(19): 5551 - 5558. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. F. Pollack, S. D. Finkelstein, J. Woods, J. Burnham, E. J. Holmes, R. L. Hamilton, A. J. Yates, J. M. Boyett, J. L. Finlay, R. Sposto, et al. Expression of p53 and Prognosis in Children with Malignant Gliomas N. Engl. J. Med., February 7, 2002; 346(6): 420 - 427. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. F. Pollack, S. D. Finkelstein, J. Burnham, E. J. Holmes, R. L. Hamilton, A. J. Yates, J. L. Finlay, and R. Sposto Age and TP53 Mutation Frequency in Childhood Malignant Gliomas: Results in a Multi-institutional Cohort Cancer Res., October 1, 2001; 61(20): 7404 - 7407. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Janss, A. Maity, C.-B. Tang, R. J. Muschel, W. G. McKenna, L. Sutton, and P. C. Phillips Decreased cyclin B1 expression contributes to G2 delay in human brain tumor cells after treatment with camptothecin Neuro-oncol, January 1, 2001; 3(1): 11 - 21. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Besson and V. W. Yong Involvement of p21Waf1/Cip1 in Protein Kinase C Alpha-Induced Cell Cycle Progression Mol. Cell. Biol., July 1, 2000; 20(13): 4580 - 4590. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Fuxe, G. Akusjärvi, H. M. Goike, G. Roos, V. P. Collins, and R. F. Pettersson Adenovirus-mediated Overexpression of p15INK4B Inhibits Human Glioma Cell Growth, Induces Replicative Senescence, and Inhibits Telomerase Activity Similarly to p16INK4A Cell Growth Differ., July 1, 2000; 11(7): 373 - 384. [Abstract] [Full Text]
|
|
|
|
|
|
E. C. Holland A Mouse Model for Glioma: Biology, Pathology, and Therapeutic Opportunities Toxicol Pathol, January 1, 2000; 28(1): 171 - 177. [Abstract] [PDF]
|
|
|
|
 |
|
 R. A. Levine and M. A. Fleischli Inactivation of p53 and Retinoblastoma Family Pathways in Canine Osteosarcoma Cell Lines Vet. Pathol., January 1, 2000; 37(1): 54 - 61. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Sills, J. R. Hailey, J. Neal, G. A. Boorman, J. K. Haseman, and R. L. Melnick Examination of Low-Incidence Brain Tumor Responses in F344 Rats Following Chemical Exposures in National Toxicology Program Carcinogenicity Studies Toxicol Pathol, September 1, 1999; 27(5): 589 - 599. [Abstract] [PDF]
|
|
|
|
 |
|
 I. P. de Castro, M. Malumbres, J. Santos, A. Pellicer, and J. Fernandez-Piqueras Cooperative alterations of Rb pathway regulators in mouse primary T cell lymphomas Carcinogenesis, September 1, 1999; 20(9): 1675 - 1682. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Harada, K. Nakagawa, S. Iwata, M. Saito, Y. Kumon, S. Sakaki, K. Sato, and K. Hamada Restoration of Wild-Type p16 Down-Regulates Vascular Endothelial Growth Factor Expression and Inhibits Angiogenesis in Human Gliomas Cancer Res., August 1, 1999; 59(15): 3783 - 3789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bredel, I. F. Pollack, R. L. Hamilton, and C. D. James Epidermal Growth Factor Receptor Expression and Gene Amplification in High-Grade Non-Brainstem Gliomas of Childhood Clin. Cancer Res., July 1, 1999; 5(7): 1786 - 1792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kamijo, S. Bodner, E. van de Kamp, D. H. Randle, and C. J. Sherr Tumor Spectrum in ARF-deficient Mice Cancer Res., May 1, 1999; 59(9): 2217 - 2222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. C. Holland, W. P. Hively, V. Gallo, and H. E. Varmus Modeling mutations in the G1 arrest pathway in human gliomas: overexpression of CDK4 but not loss of INK4a-ARF induces hyperploidy in cultured mouse astrocytes Genes & Dev., December 1, 1998; 12(23): 3644 - 3649. [Abstract] [Full Text]
|
|
|
|
|
|
E. C. Holland, W. P. Hively, R. A. DePinho, and H. E. Varmus A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice Genes & Dev., December 1, 1998; 12(23): 3675 - 3685. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. C. Holland and H. E. Varmus Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice PNAS, February 3, 1998; 95(3): 1218 - 1223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Mulligan, J. Wong, and T. Jacks p130 Is Dispensable in Peripheral T Lymphocytes: Evidence for Functional Compensation by p107 and pRB Mol. Cell. Biol., January 1, 1998; 18(1): 206 - 220. [Abstract] [Full Text]
|
|
|
|
|
|
F. B. Furnari, H. Lin, H.-J. S. Huang, and W. K. Cavenee Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain PNAS, November 11, 1997; 94(23): 12479 - 12484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Lahti, H. Li, and V. J. Kidd Elimination of Cyclin D1 in Vertebrate Cells Leads to an Altered Cell Cycle Phenotype, Which Is Rescued by Overexpression of Murine Cyclins D1, D2, or D3 but Not by a Mutant Cyclin D1 J. Biol. Chem., April 18, 1997; 272(16): 10859 - 10869. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. O'Rourke, X. Qian, H.-T. Zhang, J. G. Davis, E. Nute, J. Meinkoth, and M. I. Greene Trans receptor inhibition of human glioblastoma cells by erbB family ectodomains PNAS, April 1, 1997; 94(7): 3250 - 3255. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
